Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

RxSight (RXST) Revenue (2020 - 2026)

RxSight filings provide 6 years of Revenue readings, the most recent being $32.6 million for Q4 2025.

  • On a quarterly basis, Revenue fell 18.91% to $32.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $134.5 million, a 3.89% decrease, with the full-year FY2025 number at $134.5 million, down 3.89% from a year prior.
  • Revenue hit $32.6 million in Q4 2025 for RxSight, up from $30.3 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $40.2 million in Q4 2024 to a low of $3.5 million in Q1 2021.
  • Median Revenue over the past 5 years was $21.5 million (2023), compared with a mean of $21.8 million.
  • Biggest five-year swings in Revenue: surged 189.46% in 2021 and later dropped 18.91% in 2025.
  • RxSight's Revenue stood at $8.4 million in 2021, then skyrocketed by 90.93% to $16.1 million in 2022, then skyrocketed by 77.65% to $28.6 million in 2023, then soared by 40.71% to $40.2 million in 2024, then dropped by 18.91% to $32.6 million in 2025.
  • The last three reported values for Revenue were $32.6 million (Q4 2025), $30.3 million (Q3 2025), and $33.6 million (Q2 2025) per Business Quant data.